share_log

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Benzinga ·  Nov 16 05:55  · Ratings

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment